VanEck Biotech ETF (BBH) — ETF Analysis on Winston
Key Facts
- Issuer: VanEck
- Category: Equity
- Asset Class: Equity
- Price: $204.18
- Expense Ratio: 35.00%
- Assets Under Management: $391M
- Number of Holdings: 25
- Inception Date: 2011-12-20
- Currency: USD
Winston Score
VanEck Biotech ETF has a Winston Score of 57 out of 100.
Performance
- 1-Year Return: 23.63%
- 3-Year Return: 17.36%
- 5-Year Return: -2.90%
Top Holdings
Amgen Inc (N/A%), Gilead Sciences Inc (N/A%), Vertex Pharmaceuticals Inc (N/A%), Regeneron Pharmaceuticals Inc (N/A%), Revolution Medicines Inc (N/A%)
Sector Breakdown
Healthcare (N/A%)